Deliver to Finland
For best experience Get the App
GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.
Trustpilot
Rajesh P.
2 days ago
Anjali K.
1 month ago
Sneha T.
Ayesha M.
5 days ago
